These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9793611)
1. Comment: troglitazone drug interactions. Terra SG; Washam JB; May DB Ann Pharmacother; 1998 Oct; 32(10):1111. PubMed ID: 9793611 [No Abstract] [Full Text] [Related]
2. Comment: troglitazone. Fraser CG; Fierro L Ann Pharmacother; 1998 Oct; 32(10):1111-2. PubMed ID: 9793612 [No Abstract] [Full Text] [Related]
3. Thiazolidinediones for type 2 diabetes. No evidence exists that pioglitazone induces hepatic cytochrome P450 isoform CYP3A4. Glazer NB; Cheatham WW BMJ; 2001 Jan; 322(7280):235-6. PubMed ID: 11159615 [No Abstract] [Full Text] [Related]
4. Possible troglitazone-warfarin interaction. Plowman BK; Morreale AP Am J Health Syst Pharm; 1998 May; 55(10):1071. PubMed ID: 9606460 [No Abstract] [Full Text] [Related]
5. Troglitazone interferes with gemfibrozil's lipid-lowering action. Bell DS; Ovalle F Diabetes Care; 1998 Nov; 21(11):2028-9. PubMed ID: 9802763 [No Abstract] [Full Text] [Related]
6. Troglitazone for non-insulin-dependent diabetes mellitus. Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446 [No Abstract] [Full Text] [Related]
14. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes. Teter ML Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019 [No Abstract] [Full Text] [Related]